All states will begin testing for Covid-19 vaccination from January 2. The decision was made at a high-level meeting of the Union Ministry of Health on Thursday.
The drill will be conducted by all state and UT governments on January 2, 2021 (Saturday). The ministry proposed that the drill be held in all state capitals at at least three session sites.
“Some states will also include districts that are located in difficult terrain / have poor logistical support; Maharashtra and Kerala are likely to schedule the drill in major cities in addition to their capital, ”the Union Health Ministry said.
Previously, a two-day trial was successfully carried out to assess the readiness of the established mechanism for the Covid-19 immunization campaign in Andhra Pradesh, Gujarat, Punjab and Assam, the Union Health Ministry said on Tuesday. Field feedback from the first day of dun’s race was reviewed on December 29 via videoconference with state and district program officials by the Assistant Secretary (Public Health).
“All states expressed satisfaction in terms of operational approach and use of the IT platform to ensure transparency and effective monitoring of vaccination processes that are expected to cover a large number of people across the country.
“Additional TI platform suggestions were also noted to further improve the Co-WIN platform. Detailed insights and feedback will help enrich the IT platform and operational guidelines, and strengthen the Covid vaccine implementation plan. -19, “the ministry said. .
Dry race goal
According to the Union Ministry of Health, the objective of the trial for the introduction of the Covid-19 vaccine is to evaluate the operational feasibility in the use of the Co-WIN application in a field setting, to test the links between planning and implementation and identify challenges. and guide the way forward before actual implementation. This is also expected to give confidence to program managers at various levels, the ministry said.
Methodology
“Planning for the introduction of the vaccine will be carried out in accordance with the operational guidelines issued by the ministry on December 20, 2020. For each of the three session sites, the responsible medical officer will identify 25 beneficiaries of the trial ( health workers, ”” the ministry said.
States / UTs have been asked to ensure that the data for these beneficiaries is uploaded to Co-WIN. These beneficiaries will also be available on the session site for the drill. The states and UT will prepare the facilities and users to be created in the Co-WIN application, including uploading the health care worker (HCW) beneficiary data.
States / UTs have been asked to:
– Ensure physical verification of all proposed sites to determine the suitability of space, logistical arrangements, Internet connectivity, electricity, security, etc.
– Prepare at least three model session sites in each state (in the state capital) for the demonstration;
– Ensuring that model sites have independent entrances and exits in a “three-room configuration” with adequate outdoor space for awareness-raising activities;
– Show all IEC material on these sites;
– Ensure that all SOPs and protocols are being practiced at the identified sites in an ideal environment together with vaccination teams to be identified and trained in all aspects.
The trial will also equip the state and UT administration in managing vaccine supply, storage and logistics, including cold chain management, the ministry said.
Vaccinators
Since vaccine administrators will play an important role in the vaccination process, several states have begun to train trainers and those who should administer the vaccine. Some 96,000 vaccinators have been trained for this purpose. More than 2,300 participants in national training of trainers and more than 57,000 participants in training at the district level have been trained in 719 districts.
Help lines
States are increasing state helpline 104 (to be used in addition to 1075) for any vaccine / software related inquiries. In the states / UT, orientation and capacity building of call center executives has been carried out. States were also encouraged to use the FAQs issued by the ministry of health proactively to address any such inquiries.
Management of possible adverse effects
An important focus of the trial will be the management of any possible adverse event post-immunization (AEFI). In addition, compliance with and management of infection control practices at the session site, to prevent disease transmission. The drill will include simultaneous monitoring and review at the block and district level, and comment preparation.
The Covid-19 vaccine is expected soon
AIIMS Delhi Director Dr. Randeep Guleria said on Wednesday that India will have the Covid-19 vaccine in a few days.
Calling the approval of the Oxford-AstraZeneca vaccine for use in the UK as a ‘big step forward’, he said: ‘It is very good news that AstraZeneca has obtained approval for its vaccine from the UK regulatory authorities. They have solid data and in India and the same vaccine is being developed by the Serum Institute of India. This is a big step forward not only for India but for many parts of the world. “
“This vaccine can be stored at two to eight degrees Celsius. Therefore, it would be easy to store and transport. Storage can be done using a simple refrigerator instead of what is required in the minus 70 degrees Celsius Pfizer vaccine.” said Dr. Guleria. AND ME.
ALSO READ: Test of coronavirus vaccination campaign successfully carried out in 4 states, says Ministry of Health
